International and Australian researchers and clinicians come together in Melbourne tomorrow for forum on prevention and diagnosis of Alzheimer’s disease
This week Melbourne will play host to a global gathering of leading Alzheimer’s disease researchers and clinicians who will meet to agree on diagnostic and prognostic parameters used in Alzheimer’s research centres around the world.
A core goal in Alzheimer’s disease research is to advance the understanding of its causes and early diagnosis, and help develop preventative strategies. This will be a key focus for international experts attending the Research and Standardisation in Alzheimer’s Disease conference at the Melbourne Brain Centre in Melbourne this week.
Professor Richard Head of the CSIRO said a disease as complex as Alzheimer’s required the best global collaborations to achieve outcomes on a worldwide scale.
“This conference is a key step in that process,” Head said.
He said it would unite key international researchers, clinicians, industry, regulatory and government leaders in Alzheimer’s disease with the aim of “setting common standards for the development of imaging and biomarker strategies”.
“These agreements should speed research approaches to diagnostic methods for the disease,” he said.
Coinciding with the conference will be a lecture to engage and inform the general public on current and future avenues for research into the prevention, early detection and treatment of Alzheimer’s disease.
Speakers at the lecture include Ita Buttrose, president-elect of Alzheimer’s Australia; Dr Maria Carrillo, Alzheimer’s Association USA; and, Professor David Ames, co-chair of the AIBL study (Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing).
The Research and Standardisation in Alzheimer’s Disease conference runs from March 27 to 29 at the Melbourne Brain Centre.
For more information, go to: www.aibl.csiro.au/RASAD2012Do you have an idea for a story?
Email [email protected]